TCM Board of Directors

Get the latest insights into the leadership at TCM. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
George VargheseNon Executive Director
Rani JoseNon Executive Director
Gopalakrishnan MaheshNon Executive Independent Director
Jose JacobNon Executive Independent Director
Ramesh BabuExecutive Director
Sreenivasa Bhat SNon Executive Independent Director
Bobby JohnNon Executive Independent Director
Varghese JosephManaging Director
Gokul V ShenoyCompany Secretary & Compliance Officer

TCM Share price

TCMLMTD

49.1

0.21 (0.43%)
Last updated on 22 Apr, 2026 | 15:25 IST
Today's High

49.13

Today's Low

46.10

52 Week Low

36.53

52 Week High

81.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

TCM FAQs

The board at TCM consists of experienced professionals, including George Varghese, Rani Jose, and others, overseeing the company’s strategic and corporate governance.

Directors at TCM are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, George Varghese is the current chairman at TCM.

Executive directors at TCM are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, TCM adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At TCM, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost